Lymphocytic Leukemia Research 1.002.34 by University of Stanford

Your Diagnosis Overview

Based on the information you provided about your diagnosis, which includes chronic lymphocytic leukemia (CLL), our system has identified a specific clinical trial that aligns closely with your medical needs.

Recommended for You: CLL Advanced Treatment Study

This recommendation has been selected based on several factors pertinent to your condition, such as the progressive nature of CLL and your genetic profile.

Why This is a Suitable Match for You

The CLL Advanced Treatment Study is particularly suited to your case due to its focus on innovative gene therapy techniques. Additionally, the trial has shown a high success rate in early-stage testing and is conveniently located in your region.

Details of the Recommendation

  • Research Type: Clinical Trial
  • Location: John Hopkins Research Center, Baltimore
  • Duration: Approximately 6 months
  • Eligibility Criteria: Diagnosed with CLL, Age 30-65, No prior gene therapy treatments

Next Steps to Participate

If you are interested in this recommendation and would like to learn more or participate, you can contact the research team at cllstudy@jhopkins.com. For further assistance, feel free to reach out to our support team.